Literature DB >> 33177052

Clinical management of sickle cell liver disease in children and young adults.

Eirini Kyrana1, David Rees2, Florence Lacaille3, Emer Fitzpatrick4, Mark Davenport5, Nigel Heaton6, Sue Height7, Marianne Samyn8, Fulvio Mavilio9, Valentine Brousse10, Abid Suddle11, Subarna Chakravorty7,12, Anita Verma11, Girish Gupte13, Marki Velangi14, Baba Inusa15, Emma Drasar16, Nedim Hadzic8, Tassos Grammatikopoulos4,17, Jonathan Hind4, Maesha Deheragoda17, Maria Sellars18, Anil Dhawan19.   

Abstract

Liver involvement in sickle cell disease (SCD) is often referred to as sickle cell hepatopathy (SCH) and is a complication of SCD which may be associated with significant mortality. This review is based on a round-table workshop between paediatric and adult hepatologists and haematologists and review of the literature. The discussion was prompted by the lack of substantial data and guidance in managing these sometimes very challenging cases. This review provides a structured approach for the diagnosis and management of SCH in children and young adults. The term SCH describes any hepatobiliary dysfunction in the context of SCD. Diagnosis and management of biliary complications, acute hepatic crisis, acute hepatic sequestration and other manifestations of SCH are discussed, as well as the role of liver transplantation and haemopoietic stem cell transplantation in the management of SCH. © Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  adolescent health; gastroenterology; jaundice

Mesh:

Year:  2020        PMID: 33177052      PMCID: PMC7610372          DOI: 10.1136/archdischild-2020-319778

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  36 in total

1.  Liver transplantation in sickle cell anemia: a case of acute sickle cell intrahepatic cholestasis and a case of sclerosing cholangitis.

Authors:  Matthew M Baichi; Razi M Arifuddin; Parvez S Mantry; Adel Bozorgzadeh; Charlotte Ryan
Journal:  Transplantation       Date:  2005-12-15       Impact factor: 4.939

2.  Liver function tests in sickle cell disease.

Authors:  S Richard; H H Billett
Journal:  Clin Lab Haematol       Date:  2002-02

Review 3.  Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline.

Authors:  Amrana Qureshi; Banu Kaya; Shivan Pancham; Russell Keenan; Jeremy Anderson; Magbor Akanni; Jo Howard
Journal:  Br J Haematol       Date:  2018-05-06       Impact factor: 6.998

4.  The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).

Authors:  Ersi Voskaridou; Dimitrios Christoulas; Antonios Bilalis; Eleni Plata; Konstantinos Varvagiannis; George Stamatopoulos; Klio Sinopoulou; Aggeliki Balassopoulou; Dimitris Loukopoulos; Evangelos Terpos
Journal:  Blood       Date:  2009-11-10       Impact factor: 22.113

5.  Liver injury is associated with mortality in sickle cell disease.

Authors:  J J Feld; G J Kato; C Koh; T Shields; M Hildesheim; D E Kleiner; J G Taylor; N G Sandler; D Douek; V Haynes-Williams; J S Nichols; J H Hoofnagle; T Jake Liang; M T Gladwin; T Heller
Journal:  Aliment Pharmacol Ther       Date:  2015-08-03       Impact factor: 8.171

6.  Hepatic dysfunction in sickle cell disease: a new system of classification based on global assessment.

Authors:  Philip A Berry; Timothy J S Cross; Swee Lay Thein; Bernard C Portmann; Julia A Wendon; John B Karani; Michael A Heneghan; Adrian Bomford
Journal:  Clin Gastroenterol Hepatol       Date:  2007-09-27       Impact factor: 11.382

7.  Sickle cell disease related mortality in the United States (1999-2009).

Authors:  Dima Hamideh; Ofelia Alvarez
Journal:  Pediatr Blood Cancer       Date:  2013-04-23       Impact factor: 3.167

8.  A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease.

Authors:  Elliott Vichinsky; Onyinye Onyekwere; John Porter; Paul Swerdlow; James Eckman; Peter Lane; Beatrice Files; Kathryn Hassell; Patrick Kelly; Felicia Wilson; Françoise Bernaudin; Gian Luca Forni; Iheanyi Okpala; Catherine Ressayre-Djaffer; Daniele Alberti; Jaymes Holland; Peter Marks; Ellen Fung; Roland Fischer; Brigitta U Mueller; Thomas Coates
Journal:  Br J Haematol       Date:  2007-02       Impact factor: 6.998

9.  Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France.

Authors:  Françoise Bernaudin; Jean-Hugues Dalle; Dominique Bories; Regis Peffault de Latour; Marie Robin; Yves Bertrand; Corinne Pondarre; Jean-Pierre Vannier; Benedicte Neven; Mathieu Kuentz; Sébastien Maury; Patrick Lutz; Catherine Paillard; Karima Yakouben; Isabelle Thuret; Claire Galambrun; Nathalie Dhedin; Charlotte Jubert; Pierre Rohrlich; Jacques-Olivier Bay; Felipe Suarez; Nicole Raus; Jean-Paul Vernant; Eliane Gluckman; Catherine Poirot; Gérard Socié
Journal:  Haematologica       Date:  2019-05-16       Impact factor: 9.941

10.  Serum Total Bilirubin, not Cholelithiasis, is Influenced by UGT1A1 Polymorphism, Alpha Thalassemia and β(s) Haplotype: First Report on Comparison between Arab-Indian and African β(s) Genes.

Authors:  Said Y Alkindi; Anil Pathare; Shoaib Al Zadjali; Vinodhkumar Panjwani; Fauzia Wasim; Hammad Khan; Pradeep Chopra; Rajagopal Krishnamoorthy; Salam Alkindi
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-11-01       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.